Effectiveness of Insulin Degludec in Thai Patients with Diabetes Mellitus: Real-World Evidence From a Specialized Diabetes Center

Background Insulin degludec, an ultra-long-acting insulin analogue, has been available in Thailand since October 2016. Although clinical trial results revealed less hypoglycemia, data from real-world settings is limited especially in Asian patients. This study aimed to evaluate prospectively the rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Thewjitcharoen, Yotsapon, Yenseung, Nalin, Malidaeng, Areeya, Butadej, Siriwan, Chotwanvirat, Phawinpon, Krittiyawong, Sirinate, Thammawiwat, Chattip, Himathongkam, Thep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416321/
https://www.ncbi.nlm.nih.gov/pubmed/31597169
http://dx.doi.org/10.1055/a-0899-5118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416321/
https://www.ncbi.nlm.nih.gov/pubmed/31597169
http://dx.doi.org/10.1055/a-0899-5118

Ejemplares similares